PM: decision on the application for modification of an agreed PIP
Decision date
Decision
P/0238/2022: EMA decision of8 July 2022 on the acceptance of a modification of an agreed paediatric investigation plan for daratumumab (Darzalex), (EMEA-002152-PIP01-17-M03)